Entering text into the input field will update the search result below

Vivus awarded two patents for Qsymia

Nov. 26, 2014 8:44 AM ETVIVUS, Inc. (VVUS) StockVVUSBy: Douglas W. House, SA News Editor5 Comments
  • The USPTO issues two patents to Vivus (NASDAQ:VVUS) covering methods for effecting weight loss using Qsymia (phentermine an topiramate extended-release) (No. 8,895,057) and compositions of Qsymia (No. 8,895,058). The patents will be added to the Orange Book shortly.

Recommended For You

Related Stocks

SymbolLast Price% Chg
VVUS--
VIVUS, Inc.